Search
for
Sort by
Research 271–300 of 579
- Recommendations on trichological treatments during COVID-19 pandemic
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Free Papers Medical and Surgical: Hair and Nails
- Hair Loss in Children
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Contents Vol. 4, 2018
- Poster Abstracts
- Table of Contents
- Etiopathogenesis of Alopecia Areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Upadacitinib for the treatment of alopecia areata – A case report
- This Month in JAAD: October 2021
- Quoi de neuf en dermatologie pédiatrique ?
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Multiple Autoimmune Syndrome type 3- Thyroiditis, Vitiligo and Alopecia Areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata